D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2826
CALL
Standex International
SXI
$2.95B
| $2.72M | ﹤0.01% |
7,600
+4,100
| +117% | +$1.15M |
2025 Q3
3 quarters
|
|
2827
CALL
Workday
WDAY
$50.6B
| $2.72M | ﹤0.01% |
22,200
-133,200
| -86% | -$16.9M |
2018 Q1
33 quarters
|
|
2828
CALL
Perpetua Resources
PPTA
$2.06B
| $2.72M | ﹤0.01% |
130,900
| – | – |
2026 Q1
1 quarter
|
|
2829
New Found Gold
NFGC
$607M
| $2.71M | ﹤0.01% |
1,758,915
-326,700
| -16% | -$626K |
2025 Q2
4 quarters
|
|
2830
State Street SPDR S&P Global Natural Resources ETF
GNR
$5.19B
| $2.71M | ﹤0.01% |
+40,272
| New | +$2.94M |
2026 Q2
0 quarters
|
|
2831
PUT
Vermilion Energy
VET
$2.13B
| $2.71M | ﹤0.01% |
290,000
+50,000
| +21% | +$594K |
2024 Q3
7 quarters
|
|
2832
Haemonetics
HAE
$5.39B
| $2.7M | ﹤0.01% |
36,040
-154,610
| -81% | -$9.9M |
2025 Q4
2 quarters
|
|
2833
TTM Technologies
TTMI
$8.44B
| $2.7M | ﹤0.01% |
14,446
+1,111
| +8% | +$179K |
2015 Q2
44 quarters
|
|
|
2834
Workday
WDAY
$50.6B
| $2.7M | ﹤0.01% |
22,069
-10,073
| -31% | -$1.28M |
2018 Q4
30 quarters
|
|
2835
Castle Biosciences
CSTL
$1.01B
| $2.69M | ﹤0.01% |
112,789
-99,177
| -47% | -$2.21M |
2024 Q4
6 quarters
|
|
2836
Rubrik
RBRK
$26.7B
| $2.69M | ﹤0.01% |
33,464
-277
| -0.8% | -$17.4K |
2024 Q4
6 quarters
|
|
2837
Zai Lab
ZLAB
$2.7B
| $2.68M | ﹤0.01% |
141,158
+77,915
| +123% | +$1.54M |
2024 Q1
9 quarters
|
|
2838
CALL
Fiverr
FVRR
$304M
| $2.67M | ﹤0.01% |
259,100
| – | – |
2026 Q1
1 quarter
|
|
2839
CALL
Ball Corp
BALL
$17.1B
| $2.67M | ﹤0.01% |
+42,800
| New | +$2.52M |
2026 Q2
0 quarters
|
|
2840
GeneDx Holdings
WGS
$1.67B
| $2.67M | ﹤0.01% |
38,877
+19,974
| +106% | +$1.14M |
2025 Q4
2 quarters
|
|
2841
People Inc
PPLI
$2.87B
| $2.67M | ﹤0.01% |
57,762
-3,366
| -6% | -$144K |
2025 Q3
3 quarters
|
|
2842
Old Second Bancorp
OSBC
$1.24B
| $2.67M | ﹤0.01% |
+114,326
| New | +$2.44M |
2026 Q2
0 quarters
|
|
2843
Universal Insurance Holdings
UVE
$1.36B
| $2.66M | ﹤0.01% |
64,380
+6,850
| +12% | +$258K |
2023 Q3
11 quarters
|
|
2844
CALL
BellRing Brands
BRBR
$1.11B
| $2.66M | ﹤0.01% |
205,300
-19,700
| -9% | -$238K |
2025 Q4
2 quarters
|
|
2845
Zumiez
ZUMZ
$216M
| $2.65M | ﹤0.01% |
149,052
+52,997
| +55% | +$1.18M |
2021 Q3
19 quarters
|
|
2846
Zentalis Pharmaceuticals
ZNTL
$209M
| $2.65M | ﹤0.01% |
546,566
-937,532
| -63% | -$3.74M |
2024 Q1
9 quarters
|
|
2847
CALL
Eldorado Gold
EGO
$8.26B
| $2.65M | ﹤0.01% |
85,200
| – | – |
2025 Q4
2 quarters
|
|
2848
Metallus
MTUS
$846M
| $2.64M | ﹤0.01% |
141,258
+72,260
| +105% | +$1.36M |
2014 Q3
47 quarters
|
|
2849
Arcturus Therapeutics
ARCT
$280M
| $2.64M | ﹤0.01% |
392,358
+140,324
| +56% | +$1.11M |
2025 Q2
4 quarters
|
|
2850
QDRO Acquisition Corp
QADR
$250M
| $2.64M | ﹤0.01% |
+266,001
| New | +$2.64M |
2026 Q2
0 quarters
|
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.